Background illustration for clinical trials search

Paid Clinical Trials New Braunfels

Discover 1,416 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,416

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

for

Complex Congenital Heart Defect, Dysfunctional RVOT Conduit,

Location: San Antonio TX, Dallas TX, Little Rock AR, Memphis TN,

Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT02744677

Recruiting

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

for

Mitral Valve Regurgitation

Location: San Antonio TX, Austin TX, Houston TX, Dallas TX,

Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18+

Code: NCT03242642

Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

for

Progressive Pulmonary Fibrosis, Interstitial Lung Disease

Location: San Antonio TX, Houston TX, Dallas TX, McAllen TX,

Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT05943535

Phase3, Recruiting

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

for

Cardiovascular Risk, Acute Myocardial Infarction (AMI)

Location: San Antonio TX, Tupelo MS, Winter Haven FL, Minot ND,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT06118281

Phase3, Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for

T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

Location: San Antonio TX, Houston TX, St Louis MO, Nashville TN,

Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase2, Recruiting

Neonatal Platelet Transfusion Threshold Trial

for

Thrombocytopenia, Neonatal, Platelet Transfusion,

Location: San Antonio TX, Houston TX, Dallas TX, Albuquerque NM,

Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT06676904

Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,

Location: San Antonio TX, Dallas TX, Shreveport LA,

Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for

Multiple Myeloma

Location: San Antonio TX, Houston TX, Dallas TX, Little Rock AR,

Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for

Chronic Graft-versus-host-disease

Location: San Antonio TX, Austin TX, Memphis TN, Kansas City KS,

Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for

Large B-cell Lymphoma

Location: San Antonio TX, Austin TX, Houston TX, Dallas TX,

Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase2, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for

Multiple Myeloma

Location: San Antonio TX, Austin TX, Dallas TX, Little Rock AR,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase3, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for

Large B-cell Lymphoma, Lymphoma, B-Cell,

Location: San Antonio TX, Austin TX, Houston TX, Westwood KS,

Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase3, Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

for

Lupus Nephritis

Location: San Antonio TX, Syracuse NY, New York NY

Sponsor: Autolus Limited

Sex: All

Age: 12 - 65

Code: NCT07053800

Phase2, Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

for

B-cell Acute Lymphoblastic Leukemia

Location: San Antonio TX, Austin TX, Houston TX, Aurora CO,

Sponsor: Cellectis S.A.

Sex: All

Age: 15 - 50

Code: NCT04150497

Phase1, Phase2, Recruiting

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

for

Acute Leukemia

Location: San Antonio TX, Houston TX, Dallas TX, Albuquerque NM,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2+

Code: NCT04811560

Phase1, Phase2, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for

Refractory Diffuse Large B Cell Lymphoma (DLBCL),

Location: San Antonio TX, Houston TX, Dallas TX, Westwood KS,

Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

for

Wound of Skin, Burns

Location: San Antonio TX

Sponsor: The Metis Foundation

Sex: All

Age: 18+

Code: NCT05217160

Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for

Primary Membranous Nephropathy

Location: San Antonio TX, Houston TX, Shreveport LA, El Paso TX,

Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase2, Phase3, Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for

Geographic Atrophy, Macular Degeneration

Location: San Antonio TX, Austin TX, The Woodlands TX,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase2, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for

Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)

Location: San Antonio TX, Austin TX, Round Rock TX, Katy TX,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting

Paid Clinical Trials New Braunfels

Filter results

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Interested in new trials?

Neonatal Platelet Transfusion Threshold Trial

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

DALY II USA/ MB-CART2019.1 for DLBCL

Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy